 Biogen Inc. NASDAQ:BIIB Biogen and Sage Zuranolone Webcast December 6, 2022 8:00 AM ET Company Participants Helen Rubinstein Director-Investor Relations-Sage Therapeutics Chris Benecchi Chief Business Officer-Sage Therapeutics Maha Radhakrishnan Group Senior Vice President and Chief Medical Officer-Biogen Greg Mattingly Associate Clinical Professor-Washington University Alisha Alaimo President-Biogen-U.S. Organization Mike Hencke Head-Investor Relations-Biogen Jim Doherty Chief Development Officer-Sage Therapeutics Conference Call Participants Operator Good morning. Welcome to Sage Therapeutics and Biogens Joint Investor Webcast. 